19.01.2023 Vitruvia Medical AG  CH0461931419

EQS-News: Vitruvia Medical AG: Cooperation with TRES MEDICO, Malaysia


 

EQS-News: Vitruvia Medical AG / Key word(s): Alliance
Vitruvia Medical AG: Cooperation with TRES MEDICO, Malaysia

19.01.2023 / 11:47 CET/CEST
The issuer is solely responsible for the content of this announcement.


Anglikon, January 19, 2023:

New cooperation of LT technologies Gmbh & Co. KG with TRES MEDICO, Malaysia

Our affiliate LT technologies has entered a cooperation in the field of repair service with the Malaysian company TRES MEDICO, a 100% subsidiary of HG Medic Sdn Bhd, Malaysia.

As one of the few German companies in the repair service of surgical instruments, LT technologies can also offer its service "Made in Germany" internationally in Malaysia. Numerous hospitals, especially in the private hospital sector, are interested in our repair service, because until now surgical instruments were disposed of after use. With our repair service we offer through our partner TRES MEDICO cost saving potential as well as sustainable handling of surgical instruments to the hospitals. Demand is increasing and first orders are in the pipeline.

 

About HG Medic Sdn Bhd, Malaysia:

Established in 2014, HG Medic Sdn Bhd are a healthcare solutions provider and distributor of medical devices and consumables in Malaysia. The subsidiary TRES MEDICO was established for the repair service business in Malaysia and Southeast Asia, providing LT technologies services.

 

About Vitruvia Medical AG

Vitruvia Medical AG is a Swiss holding company focusing on repair, production and trade of medical devices as well as surgical instruments. Thus, Vitruvia combines innovative and sustainable solutions for medical-technical progress, customer benefit and economic success.                                                                                   

 

 

 



19.01.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Vitruvia Medical AG
Kesselackerstr. 18
5611 Anglikon
Switzerland
Phone: +41 44 915 33 78
E-mail: [email protected]
Internet: www.vitruvia-med.com
ISIN: CH0461931419
WKN: A2PDWF
Listed: Regulated Unofficial Market in Munich
EQS News ID: 1539171

 
End of News EQS News Service

1539171  19.01.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1539171&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 0,00 0,00 0,00 5,60 1,97 1,42 0,00
EBITDA1,2 0,00 0,00 0,00 -0,96 -0,75 -0,91 0,00
EBITDA-Marge3 0,00 0,00 0,00 -17,14 -38,07 -64,08
EBIT1,4 0,00 0,00 0,00 -1,31 -7,69 -1,24 0,00
EBIT-Marge5 0,00 0,00 0,00 -23,39 -390,36 -87,32 0,00
Jahresüberschuss1 0,00 0,00 0,00 -1,54 -7,71 -1,48 0,00
Netto-Marge6 0,00 0,00 0,00 -27,50 -391,37 -104,23 0,00
Cashflow1,7 0,00 0,00 0,00 -0,21 -0,78 -0,67 0,00
Ergebnis je Aktie8 0,00 0,00 0,00 -0,85 -4,19 -0,59 -0,15
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

INVESTOR-INFORMATIONEN
©boersengefluester.de
Vitruvia Medical
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A2PDWF 0,500 1,26
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
0,00 0,00 0,00 -0,20
KBV KCV KUV EV/EBITDA
-0,64 - 0,89 -1,35
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 26.07.2023
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
30.09.2023 26.06.2023
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-22,24% -39,83% -58,33% -75,00%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Vitruvia Medical AG  ISIN: CH0461931419 können Sie bei EQS abrufen


Medtech , A2PDWF , 991 , MUN:991